Streetbeat News

MGX

Metagenomi Inc.

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Open

1.70

Mkt cap

62M

Volume

381K

High

1.72

P/E Ratio

-0.74

52-wk high

12.74

Low

1.62

Div yield

N/A

52-wk low

1.62

The Gross Law Firm has issued a notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX) to contact them before November 25, 2024, to discuss their rights.

Portfolio Pulse from

November 20, 2024 | 6:00 pm

Levi & Korsinsky has notified investors of Metagenomi, Inc. (NASDAQ:MGX) about a class action lawsuit. Investors who suffered losses can learn about potential recovery under federal securities laws.

Portfolio Pulse from

November 20, 2024 | 4:45 pm

The Schall Law Firm has filed a class action lawsuit against Metagenomi Inc. for alleged violations of federal securities laws related to its IPO. Investors who purchased Metagenomi's securities are encouraged to participate in the lawsuit.

Portfolio Pulse from

November 20, 2024 | 4:15 pm

Levi & Korsinsky has filed a securities class action lawsuit on behalf of Metagenomi, Inc. (NASDAQ:MGX) shareholders. Investors who suffered losses can seek potential recovery under federal securities laws.

Portfolio Pulse from

November 20, 2024 | 3:45 pm

Pomerantz Law Firm has filed a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX). Investors are encouraged to contact the firm for more information.

Portfolio Pulse from

November 20, 2024 | 3:15 pm

Metagenomi, Inc. (NASDAQ:MGX) is facing a lawsuit for securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky by November 25, 2024, to discuss potential recovery options.

Portfolio Pulse from

November 20, 2024 | 12:45 pm

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) and certain officers for alleged violations of federal securities laws related to their IPO. The lawsuit seeks damages for investors who acquired Metagenomi securities during the specified class period.

Portfolio Pulse from

November 20, 2024 | 12:15 pm

Levi & Korsinsky has issued a reminder to investors of Metagenomi, Inc. (NASDAQ:MGX) about a pending class action lawsuit. Investors who suffered losses have until November 25, 2024, to act as lead plaintiffs.

Portfolio Pulse from

November 20, 2024 | 3:45 am

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) seeking recovery for investors who suffered losses. Investors are encouraged to contact Levi & Korsinsky for more information.

Portfolio Pulse from

November 20, 2024 | 12:00 am

Portfolio Pulse from

November 19, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.